Title
Dyslipidemia Management In Women Of Reproductive Potential
Authoring Organization
Publication Month/Year
May 31, 2024
Last Updated Month/Year
June 6, 2024
Supplemental Implementation Tools
Document Type
Consensus
Country of Publication
US
Document Objectives
Cardiovascular disease (CVD) is the leading cause of death among women and its incidence has been increasing recently, particularly among younger women. Across major professional society guidelines, dyslipidemia management remains a central tenet for atherosclerotic CVD prevention for both women and men. Despite this, women, particularly young women, who are candidates for statin therapy are less likely to be treated and less likely to achieve their recommended therapeutic objectives for low-density lipoprotein cholesterol (LDL-C) levels. Elevated LDL-C and triglycerides are the two most common dyslipidemias that should be addressed during pregnancy due to the increased risk for adverse pregnancy outcomes, such as preeclampsia, gestational diabetes mellitus, and pre-term delivery, as well as pancreatitis in the presence of severe hypertriglyceridemia. In this National Lipid Association. Highlights:
Suboptimal cardiovascular health implies major risk for adverse pregnancy outcomes.
Atherosclerosis prevention begins with healthy lifestyle and cardioprotective diet.
Counseling for diet and physical activity provides evidence-based risk improvement.
Maternal and fetal risks of abnormal lipids should be clarified and addressed.
Lifelong care should include medical optimization and contraception advice.
Target Patient Population
Women Of Reproductive Potential
Inclusion Criteria
Female, Adult
Health Care Settings
Ambulatory
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Treatment, Management
Diseases/Conditions (MeSH)
D050171 - Dyslipidemias
Keywords
blood cholesterol, cholesterol, dyslipidemia, familial hypercholesterolemia, women, women's health
Source Citation
Agarwala et al, Dyslipidemia management in women of reproductive potential: An expert clinical consensus from the national lipid association, Journal of Clinical Lipidology, https://doi.org/10.1016/j.jacl.2024.05.005